IE791036L - Thienopyridines and furanopyridines - Google Patents
Thienopyridines and furanopyridinesInfo
- Publication number
- IE791036L IE791036L IE791036A IE103679A IE791036L IE 791036 L IE791036 L IE 791036L IE 791036 A IE791036 A IE 791036A IE 103679 A IE103679 A IE 103679A IE 791036 L IE791036 L IE 791036L
- Authority
- IE
- Ireland
- Prior art keywords
- compounds
- halogen
- furanopyridines
- thienopyridines
- cyclisation
- Prior art date
Links
- YRTCKZIKGWZNCU-UHFFFAOYSA-N furo[3,2-b]pyridine Chemical class C1=CC=C2OC=CC2=N1 YRTCKZIKGWZNCU-UHFFFAOYSA-N 0.000 title 1
- 229940125670 thienopyridine Drugs 0.000 title 1
- 239000002175 thienopyridine Substances 0.000 title 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 210000001772 blood platelet Anatomy 0.000 abstract 1
- 229910052736 halogen Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- WLMSZVULHUTVRG-UHFFFAOYSA-N prop-2-enoyl azide Chemical class C=CC(=O)N=[N+]=[N-] WLMSZVULHUTVRG-UHFFFAOYSA-N 0.000 abstract 1
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical group OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 abstract 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
- 229910052717 sulfur Chemical group 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229930192474 thiophene Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Therapeutic compositions having, in particular, blood-platelet aggregation inhibiting and anti- inflammatory activities comprising, have as active ingredient, an efficient amount of a thienopyridone derivative having the following general formulae: <IMAGE> in which X is an oxygen or sulfur atom, R is hydrogen or halogen or a C1-4 alkyl radical and Ar represents an aryl or heteroaryl group optionally substituted with at least a halogen atom or a lower alkyl, lower alkoxy, hydroxy, trifluoromethyl or nitro group. The compounds are prepared by cyclisation of a furan or thiophene substituted acrylic acid azide to form the pyridone ring. The compounds other than where R is H, X is 5 and Ar is phenyl are claimed per se.
[EP0006772A1]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7818684A FR2429219A1 (en) | 1978-06-22 | 1978-06-22 | MEDICINE BASED ON THIENOPYRIDONE OR FUROPYRIDONE DERIVATIVES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE791036L true IE791036L (en) | 1979-12-22 |
| IE48418B1 IE48418B1 (en) | 1985-01-09 |
Family
ID=9209842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1036/79A IE48418B1 (en) | 1978-06-22 | 1979-08-08 | Therapeutic composition containing thienopyridone or furopyridone derivatives |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0006772B1 (en) |
| JP (1) | JPS552698A (en) |
| BE (1) | BE877157A (en) |
| CH (1) | CH638214A5 (en) |
| DE (1) | DE2961213D1 (en) |
| DK (1) | DK259379A (en) |
| FR (1) | FR2429219A1 (en) |
| GB (1) | GB2023599B (en) |
| IE (1) | IE48418B1 (en) |
| IT (1) | IT1117227B (en) |
| LU (1) | LU81237A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57147852A (en) * | 1981-03-10 | 1982-09-11 | Toshiba Corp | Mask convergence-type color picture tube |
| JPS5818845A (en) * | 1981-07-24 | 1983-02-03 | Toshiba Corp | Color cathode-ray tube |
| EP0360868A4 (en) * | 1988-02-02 | 1991-07-24 | Dainippon Screen Mfg. Co., Ltd. | Slot-type shadow mask |
| EP1368306B1 (en) * | 2001-01-18 | 2013-01-16 | Welichem Biotech Inc. | Novel 1,2-diphenylethene derivatives for treatment of immune diseases |
| EP1594863A1 (en) * | 2003-02-11 | 2005-11-16 | Prosidion Limited | Tri(cyclo) substituted amide glucokinase activator compounds |
| US20110275707A1 (en) * | 2008-12-19 | 2011-11-10 | Kuo-Hsiung Lee | Substituted afpo (6-aryl-4h-furo[3,2-c]pyran-4-one) derivatives as anti-cancer agents |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2115006A1 (en) * | 1970-11-20 | 1972-07-07 | Anvar | 2,7-dinitro and 2-nitro furo 3,2-c pyridine - useful as antibacterials |
| GB1576511A (en) * | 1977-03-29 | 1980-10-08 | Parcor | Thieno(2,3 - c) and (3,2 - c) pyridines process for their preparation and therapeutic applications thereof |
-
1978
- 1978-06-22 FR FR7818684A patent/FR2429219A1/en active Granted
-
1979
- 1979-04-30 CH CH402979A patent/CH638214A5/en not_active IP Right Cessation
- 1979-05-02 EP EP79400282A patent/EP0006772B1/en not_active Expired
- 1979-05-02 DE DE7979400282T patent/DE2961213D1/en not_active Expired
- 1979-05-09 LU LU81237A patent/LU81237A1/en unknown
- 1979-06-21 DK DK259379A patent/DK259379A/en not_active Application Discontinuation
- 1979-06-21 BE BE0/195879A patent/BE877157A/en not_active IP Right Cessation
- 1979-06-21 IT IT49482/79A patent/IT1117227B/en active
- 1979-06-22 GB GB7921911A patent/GB2023599B/en not_active Expired
- 1979-06-22 JP JP7897579A patent/JPS552698A/en active Granted
- 1979-08-08 IE IE1036/79A patent/IE48418B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0006772A1 (en) | 1980-01-09 |
| FR2429219B1 (en) | 1980-10-24 |
| EP0006772B1 (en) | 1981-11-04 |
| IE48418B1 (en) | 1985-01-09 |
| DE2961213D1 (en) | 1982-01-14 |
| GB2023599B (en) | 1982-11-03 |
| IT1117227B (en) | 1986-02-17 |
| DK259379A (en) | 1979-12-23 |
| GB2023599A (en) | 1980-01-03 |
| BE877157A (en) | 1979-12-21 |
| FR2429219A1 (en) | 1980-01-18 |
| CH638214A5 (en) | 1983-09-15 |
| LU81237A1 (en) | 1979-09-10 |
| JPS552698A (en) | 1980-01-10 |
| JPS6345394B2 (en) | 1988-09-09 |
| IT7949482A0 (en) | 1979-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU47099B (en) | PROCEDURE FOR PREPARATION OF MACROLIDE COMPOUNDS | |
| ES436124A1 (en) | Herbicidal compositions | |
| ES480542A1 (en) | Imidazole derivatives, their preparation and pharmaceutical compositions. | |
| IE831568L (en) | Heterocyclic compounds | |
| AU537028B2 (en) | Imidazole derivatives | |
| IE873531L (en) | 1H-imidazole-5-carboxylic acid derivatives | |
| HK94986A (en) | Therapeutic agents | |
| JPS5432460A (en) | Cycloalkylidenemethylphenylacetic acid derivative and their preparation | |
| IE42628L (en) | 1,3,4-oxadiazoline derivatives | |
| IE791036L (en) | Thienopyridines and furanopyridines | |
| IE43651L (en) | Benzisoquinolin-piperidine derivatives | |
| ES8401926A1 (en) | Hydroxybenzylamino-aryl compounds, process for preparing and pharmaceutical compositions containing the same. | |
| ES8105330A1 (en) | Thiazolo (2,3-b) benzo (and azabenzo) thiazole derivatives, process for their preparation and pharmaceutical compositions containing them. | |
| IE801789L (en) | Nitrosourea derivatives. | |
| JPS5424882A (en) | Novel heterocyclic compounds and their preparation | |
| JPS57197218A (en) | Central nervous system depressant containing thiazoline- 5-carboxylic acid derivative | |
| IE831075L (en) | Thiophene derivatives | |
| ES477401A1 (en) | Thieno (3,2-c)- and thieno (2,3-c)pyridines, process for their preparation and their therapeutical application. | |
| IE56365B1 (en) | Treatment of migraine with n-alkyl-piperidinyl benzoate derivatives | |
| IE45587L (en) | Diazepinoheterocyclic compounds | |
| SE7501871L (en) | ||
| JPS5511502A (en) | Preparation of condensed heterocyclic compound | |
| JPS5484597A (en) | Novel heterocyclic compound and its preparation | |
| IE791205L (en) | Novel oxothia compounds, processes for their preparation,¹pharmaceutical preparations containing these compounds and¹such compounds for therapeutic use | |
| JPS55104266A (en) | Novel pyridone derivative |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed |